human at-tropomyosin has tumor-suppressor properties in vivo [Rastinejad, F., Conboy, M. J., Rando, T. A. & Blau, H. M. (1993) Cell 75, [1107] [1108] [1109] [1110] [1111] [1112] [1113] [1114] [1115] [1116] [1117] . Here we report that purified RNA from the 3'UTR of human a-tropomyosin can inhibit in vitro translation in a manner consistent with activation of PKR. Inhibition of translation by tropomyosin 3'UTR RNA was observed in a rabbit reticulocyte lysate system, which is known to contain endogenous PKR but was not seen in wheat germ lysate, which is not responsive to a known activator of PKR. A control RNA purified in the same manner as the 3'UTR RNA did not inhibit translation in either system. The inhibition of translation observed in reticulocyte lysates was prevented by the addition of adenovirus virus-associated RNA1 (VA RNA,), an inhibitor of PKR activation. Tropomyosin 3'UTR RNA was bound by immunoprecipitated PKR and activated the enzyme in an in vitro kinase assay. These data suggest that activation of PKR could be the mechanism by which tropomyosin 3'UTR RNA exerts its tumor-suppression activity in vivo.
The interferon-induced protein kinase PKR [also designated DAI, eukaryotic initiation factor 2a (eIF-2)a) kinase, p68] was first characterized as a part of the mammalian interferonmediated antiviral response (1) (2) (3) (4) . Although interferon induces increased expression of PKR, the newly synthesized protein is inactive. Activation of PKR occurs after binding to double-stranded RNA (dsRNA), which can be produced during a viral infection (5, 6) . PKR is autophosphorylated concomitantly with activation. Active PKR phosphorylates eIF2a, and this phosphorylation event blocks the GDP-GTP exchange cycle required for eIF-2 function (7) (8) (9) . Functional eIF-2 is required for every translation initiation event; therefore, phosphorylation of this factor leads to a general inhibition of translation (10) . Because viruses are obligate intracellular parasites that depend on their host cell for translation, the viral life cycle can be blocked by this inhibition of translation. Many viruses encode or induce inhibitors of PKR that allow them to replicate in the presence of interferon and potentially active PKR (11, 12) . The best characterized of these is adenovirus VA RNA&, a specialized RNA that binds to PKR and inhibits its activation (13, 14) . Vaccinia virus (15) (16) (17) (18) , rotavirus (19), reovirus (20), influenza virus (21, 22) , and poliovirus
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(23, 24) also inhibit PKR. The fact that most of the bestcharacterized pathogenic animal viruses have inhibitors of PKR suggests that inhibition of this enzyme is important for viral replication.
In addition to its role in antiviral response, PKR has been implicated as a tumor suppressor. NIH 3T3 cells expressing an inactive mutant of human PKR displayed morphological and growth pattern alterations consistent with a transformed phenotype (25, 26) . When these cells were injected into nude mice, tumor formation occurred in all animals. In cells expressing the mutant human PKR, endogenous murine PKR was present at normal levels but could not be activated by the addition of dsRNA. This latter observation is consistent with earlier reports that mutants of PKR that are kinase-deficient act in a trans-dominant manner to inhibit activation of wild-type PKR (27, 28) . Expression of mutant, catalytically inactive forms of the enzyme in transfected cells could act in a trans-dominant manner to inhibit endogenous wild-type PKR. This suppression of PKR activation may lead to an increased rate of cellular protein synthesis and the increased rate of cell growth characteristic of neoplasia.
The genes encoding cytoskeletal proteins such as a-tropomyosin, troponin, and a-cardiac actin are expressed in muscle tissues during differentiation. Complementation studies with murine cell lines have demonstrated that expression of these genes can rescue differentiation-deficient cell lines and trigger the expression of tissue-specific gene products (29). The complementation activities of a-tropomyosin, troponin, and a-cardiac actin were found to map to their 3' untranslated regions (3'UTRs) . Further study of a-tropomyosin showed that a plasmid encoding the 3'UTR sequence can also act as a tumor suppressor and that RNA expression is required for this activity (30). Expression of cytoskeletal proteins such as tropomyosin, troponin, and a-cardiac actin may be incompatible with neoplasia. The intracellular concentrations of mRNAs encoding isoforms of tropomyosin are known to decrease in neoplasmic cells and increase when cells revert to normal (31). Constitutive expression of tropomyosin 1 cDNA in cells transformed by ras was found to suppress neoplastic growth (32).
In view of the evidence that PKR may act as a tumor suppressor and the possible role of some 3'UTR RNAs in differentiation and tumor suppression, we investigated the effects of purified 3'UTR RNA of human a-tropomyosin on translation. We found that purified RNA from the 3'UTR of a-tropomyosin (designated Tml-3 RNA) inhibited translation in a manner analogous to a prototypical viral PKR activator, reovirus dsRNA. Namely, Tml-3 RNA inhibited translation in a PKR-positive system but did not do so in a PKR-deficient system, and inhibition in the PKR-positive system could be prevented by the addition of VA RNA,. A MgCl2/100 mM KCl/1 mM dithiothreitol/10 ,uM AEBSF/0.1 mM EDTA/bovine serum albumin at 0.1 mg/ml) containing tRNA at 0.1 mg/ml. The final pellet was resuspended in binding buffer with tRNA at 0.1 mg/ml. Radiolabeled RNAs were added to separate aliquots of washed resin, and reactions were incubated for 5 min at 30°C and then for 30 min at 4°C.
The resins were washed once in binding buffer containing tRNA at 0.1 mg/ml and then washed three times in binding buffer without tRNA. Bound radiolabeled RNAs were quantitated by using liquid scintillation counting.
PKR Kinase Assay. PKR purified by column chromatography (40) 
RESULTS
Purified RNA from the 3'UTR of Tropomyosin Inhibits Translation in Rabbit Reticulocyte Lysate. Purified RNAs were tested for their ability to activate PKR and inhibit translation in rabbit reticulocyte lysate using an assay modified from the technique of Gunnery et al. (41) . This assay is based on the fact that endogenous PKR in a rabbit reticulocyte lysate can be activated by the addition of exogenous activating RNA such as reovirus dsRNA. Activation of PKR results in a decrease in translation of a reporter mRNA. This assay has been used to detect PKR inhibitors and to compare the relative activities of mutants within inhibitory RNA sequences (41). Using the reporter mRNA luciferase, translation can be assessed by luciferase activity. This technique was used to examine effects on translation of purified a-tropomyosin 3'UTR RNA from the clone Tml-3 (Tml-3 RNA). Tml-3 RNA contains 515 bp from the tropomyosin 3'UTR, starting at the termination codon. LS1, a mutant of adenovirus VA RNA&, was chosen as a control RNA. In contrast to wild-type VA RNA1. LS1 does not inhibit activation of PKR (35, 42).
Reovirus dsRNA was also included in the assay because it has been well-characterized as an activator of PKR (43, 44) .
The results of the in vitro translation assay with reovirus dsRNA, Tml-3 RNA, and LS1 RNA are shown in Fig. 1 . As expected, addition of reovirus dsRNA led to an inhibition of luciferase mRNA translation. Addition of purified Tml-3 RNA also resulted in a decrease in translation. In contrast, addition of purified LS1 RNA had no effect on translation. A shortened tropomyosin RNA, consisting of 133 bases at the 3' end of Tml-3 and designated Tm2-3 RNA, was also tested and did inhibit translation (data not shown). The work of Rastinejad et al. (30) showed that the in vivo tumor-suppressor function of tropomyosin RNA was present in the 3' half of the tropomyosin 3'UTR. Our results, which showed little difference between Tml-3 RNA and Tm2-3 RNA, are consistent with this observation.
At the highest concentration of reovirus dsRNA, inhibition of translation decreased slightly. This result is in keeping with the previously reported bell-shaped curve of PKR activation by dsRNA. High concentrations of dsRNA are known to be inhibitory to PKR activation (45). It is not clear whether Tml-3 RNA would follow a similar pattern at higher concentrations.
As shown in Fig. 1 , similar levels of inhibition of translation were seen with 5 nM Tml-3 RNA (corresponding to 800 ng/ml) and reovirus dsRNA at 10 ng/ml. Thus, on a mass basis, Tml-3 RNA required higher concentrations to cause comparable levels of PKR activation. However, little is known of the percentage of PKR activation required in vivo to mediate significant effects including differentiation, growth suppression, and tumor suppression.
Purified RNA from 3' UTR of Tropomyosin Does Not Inhibit Translation in Wheat Germ Lysate. If the decrease in translation seen in rabbit reticulocyte lysates were due to PKR activation, a PKR-deficient translation system would not be affected. Wheat germ lysate was chosen as a PKR-deficient system. Wheat germ lysate is not responsive to reovirus dsRNA (Fig. 2) Proc. Natl. Acad. Sci. USA 93 (1996) PKR (data not shown). On the basis of these results, wheat germ lysate was assumed to be effectively PKR-deficient.
The effects of reovirus dsRNA, Tml-3 RNA, and LS1 RNA on translation in wheat germ as compared with rabbit reticulocyte are shown in Fig. 2 . Luciferase mRNA was effectively translated in both systems. Addition of LS1 RNA did not significantly affect translation in either system. Although both reovirus dsRNA and Tml-3 RNA inhibited translation in rabbit reticulocyte lysate, neither inhibited translation significantly in wheat germ lysate.
Inhibition of Translation in Rabbit Reticulocyte Lysate Can Be Prevented by the Addition of PKR Inhibitor. The observation that Tml-3 RNA inhibits translation in rabbit reticulocyte lysate but does not do so in wheat germ could be explained by differences in translation factors between the two systems: Tml-3 RNA might inhibit a translation factor that is not present or is less sensitive in wheat germ. However, if the decrease in translation seen in rabbit reticulocyte lysates was due to PKR activation, a specific PKR inhibitor such as VA RNA, would be expected to prevent the inhibition. VA RNA, would not prevent inhibition of translation that was due to putative factors specific to rabbit reticulocyte or more sensitive in rabbit reticulocyte lysate. The results in Fig. 2 show that VA RNA, blocked the inhibitory effects of Tml-3 RNA and reovirus dsRNA on translation in rabbit reticulocyte lysate.
The presence of VA RNA, did not affect the wheat germ lysate result for any of the RNAs tested (data not shown).
Inhibition of Translation by the 3' UTR Is Not Due to dsRNA Contamination from T7 Transcription. There have been reports that T7 RNA polymerase in vitro transcription can produce dsRNA contaminants that have the potential to activate PKR and inhibit translation (34). Activation of PKR by these contaminating RNAs was reported to be eliminated by digestion with RNase III, a nuclease specific for dsRNA but unaffected by digestion with RNase Tl, a nuclease specific for single-stranded RNA. As described, the 3'UTR RNAs and LS1 RNA were purified through two gels, in accordance with a published protocol for eliminating these dsRNA contaminants (34). To 
